Efficacy of the trivalent influenza vaccination in thai patients with hemodialysis or kidney transplant compared with healthy volunteers

Journal of the Medical Association of Thailand

Volumn 96, Issue SUPPL.3, 2013, Pages 1-7

  Krairittichai, Udom ^a   Chittaganpitch, Malinee ^b  

^a RANGSIT UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

H1N1 influenza a virus infection; Influenza vaccine

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ERYTHEMA; FEMALE; FEVER; FOLLOW UP; HEMAGGLUTINATION INHIBITION TEST; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INJECTION SITE ERYTHEMA; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

ADULT; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY TRANSPLANTATION; MALE; RENAL DIALYSIS; THAILAND;

EID: 84876889077     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. World Health Organization. Influenza-like illness in the United States and Mexico [Internet]. 2011 [cited 2011 Oct 11]. Available from: http://www.who. int/csr/don/2009_04_24/en/index.html.
2. Centers for Disease Control and Prevention (CDC). Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 1351-6.
3. Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M. VAESCO-GBS Case- Control Study Group. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 2011; 343: d3908.
4. World Health Organization. Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season [Internet]. 2010 [cited 2010 Jun 24]. Available from: http:// www.who.int/influenza/vaccines/virus/ recommendations/201002_Recommendation.pdf
5. Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58: 1-8.
6. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2011 southern hemisphere influenza season. [Internet]. 2011 [cited 2011 Feb 23]. Available from: http://www.who.int/influenza/vaccines/virus/ recommendations/201009_Recommendation.pdf
7. Beyer WE, Palache AM, Luchters G, Nauta J, Osterhaus AD. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 2004; 103: 125-132.
8. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361: 2405-2413.
9. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoche MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010; 375: 41-8.
10. United States Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season [Internet]. 2009 [cited 2009 Dec 15]. Available from: http://www.cdc.gov/h1n1flu/ recommendations.htm
11. Echevarria-Zuno S, Mejia-Arangure JM, Mar- Obeso AJ, Grajales-Muniz C, Robles-Perez E, Gonzalez-Leon M, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; 374: 2072-9.
12. Lee EH, Wu C, Lee EU, Stoute A, Hanson H, Cook HA, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010; 50: 1498-504.
13. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2007; (2): CD001269.
14. Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1994; 43: 1-13.
15. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 2003; 63: 738-43.
16. Ljungman P, Andersson J, Aschan J, Barkholt L, Ehrnst A, Johansson M, et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993; 17: 244-7.
17. Vilchez RA, McCurry K, Dauber J, Lacono A, Griffith B, Fung J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 287-91.
18. Keane WR, Helderman JH, Luby J, Gailiunas P, Hull AR, Kokko JP. Epidemic renal transplant rejection associated with influenza A victoria. Proc Clin Dial Transplant Forum 1978; 8: 232-6.
19. Crespo M, Collado S, Mir M, Cao H, Barbosa F, Serra C, et al. Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol 2011; 6: 2208-14.
20. Scharpe J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, et al. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis 2009; 54: 77-85.
21. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial 2007; 20: 440-51.
22. Litjens NH, Huisman M, van den DM, Betjes MG. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol 2008; 19: 1483-90.
23. Agrawal S, Gollapudi P, Elahimehr R, Pahl MV, Vaziri ND. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol Dial Transplant 2010; 25: 737-46.
24. Dinits-Pensy M, Forrest GN, Cross AS, Hise MK. The use of vaccines in adult patients with renal disease. Am J Kidney Dis 2005; 46: 997-1011.
25. Temiz G, Kasifoglu N, Kiris A, Ozturk S, Sahin G, Yalcin AU, et al. Immune response after a single vaccination against 2009 influenza A H1N1 in hemodialysis patients. Ren Fail 2010; 32: 716-20.
26. Briggs WA, Rozek RJ, Migdal SD, Shillis JL, Brackett RG, Brandon FB, et al. Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann Intern Med 1980; 92: 471-7.
27. Wyzgal J, Brydak LB, Zygier D, Paczek L, Rowinski W, Grochowiecki T. Study on efficacy of influenza vaccination in renal allograft recipients. Transplant Proc 2002; 34: 572-5.
28. Versluis DJ, Beyer WE, Masurel N, Wenting GJ, Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 1986; 42: 376-9.
29. Smith KG, Isbel NM, Catton MG, Leydon JA, Becker GJ, Walker RG. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998; 13: 160-4.
30. Sanchez-Fructuoso AI, Prats D, Naranjo P, Fernandez-Perez C, Gonzalez MJ, Mariano A, et al. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 2000; 69: 436-9.
31. Blumberg EA, Albano C, Pruett T, Isaacs R, Fitzpatrick J, Bergin J, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22: 295-302.
32. Manuel O, Pascual M, Hoschler K, Giulieri S, Alves D, Ellefsen K, et al. Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis 2011; 52: 248-56.
33. Kilbourne ED. Influenza immunity: new insights from old studies. J Infect Dis 2006; 193: 7-8.
34. Schwebke J, Mujais S. Vaccination in hemodialysis patients. Int J Artif Organs 1989; 12: 481-4.
35. Kausz AT, Gilbertson DT. Overview of vaccination in chronic kidney disease. Adv Chronic Kidney Dis 2006; 13: 209-14.